Cytek Biosciences Q3 EPS $(0.04) Beats $(0.05) Estimate, Sales $52.293M Beat $51.489M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 500 percent decrease over earnings of $0.01 per share from the
Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 500 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $52.293 million which beat the analyst consensus estimate of $51.489 million by 1.56 percent. This is a 1.54 percent increase over sales of $51.500 million the same period last year.